News Tag: HIV/AIDS

Viral HIV vaccine gives durable protection against tough strains

A nontraditional HIV vaccine from Farzan lab gives durable protection against two hard-to-fight lab strains, including one dubbed “the death star” due to how many vaccine candidates it has killed.

Scripps Research discoveries pave way to clinical trial of new type of HIV vaccine

The International AIDS Vaccine Initiative (IAVI) announced the start of a Phase I clinical trial to test a novel HIV vaccine candidate, an advance in vaccine design enabled by Scripps Research discoveries.

Engineered immune cells produce antibodies to fight HIV

Cells removed from patients’ bloodstreams and genetically altered may allow more effective vaccines for HIV, influenza, hepatitis.

HIV vaccine protects non-human primates from infection

For more than 20 years, scientists at Scripps Research have chipped away at the challenges of designing an HIV vaccine. Now new research, published in Immunity, shows that their experimental vaccine strategy works in non-human primates.

Scripps Research scientists unveil promising new HIV vaccine strategy

A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests.